Remote patient monitoring company Clear Arch Health on Thursday expanded its new connected health devices to ensure timely clinical touchpoints for Coronavirus Disease 2019 (COVID-19) and Chronic Obstructive Pulmonary Disease (COPD) management.
According to the company, the expanded product portfolio includes thermometer, peak flow meter, spirometer and pulse oximeter to support multiple conditions and provide clinical teams access to patient generated health data to manage high-risk patient populations.
In the wake of COVID-19, there is an increased need for telehealth services and access to remote health data as people have opted to avoid in-person care. Clinicians are concerned that delaying care, whether it is a routine visit or a necessary trip to the emergency room, could exacerbate symptoms or cause further health complications in patients with existing COPD, asthma and pneumonia, said the company.
The company's platform features offer multi-modal communications, including real time vitals monitoring, alert logic, compliance virtual reminders, enhanced audio, dedicated user interface with visual data, health-related surveys and questionnaires and patient education. All devices are wireless and automatically connect to a communications hub to notify clinical teams about a patient's health status.
QT Imaging signs exclusive USD33m distribution deal with Gulf Medical in Saudi Arabia
Novocure submits FDA PMA for Tumor Treating Fields therapy in pancreatic cancer
Covalon Technologies secures DTC eligibility to expand US investor access
Navamedic ASA secures final approvals for Flexilev in OraFID across Nordic markets
Oncopeptides partners with SD Pharma to expand Pepaxti access in Spain
Aptar launches bio-based nasal spray pump with Haleon's Otrivin brand
MAP Medical agrees distribution deal with Metrix-Secure
PharmaJet signs MOU with Egyptian UPA and EVA Pharma to introduce needle-free vaccine delivery
Alcon to acquire LumiThera and its FDA-authorised photobiomodulation device for dry AMD treatment
Predictmedix AI launches mobile diabetes screening platform in India
Navamedic's medical device OraFID approved as primary package for a pharmaceutical product
Speranza Therapeutics partners with Sunshine Labs for harm reduction solutions
Immuno Cure and PharmaJet collaborate for novel HIV therapeutic DNA vaccine advancement